Abbott Laboratories (NYSE:ABT) Given New $154.00 Price Target at The Goldman Sachs Group
Abbott Laboratories (NYSE:ABT – Free Report) had its price objective boosted by The Goldman Sachs Group from $138.00 to $154.00 in a report issued on Tuesday morning,Benzinga reports. The Goldman Sachs Group currently has a buy rating on the healthcare product maker’s stock. Several other analysts have also issued reports on ABT. StockNews.com lowered shares […]
Abbott Laboratories (NYSE:ABT – Free Report) had its price objective boosted by The Goldman Sachs Group from $138.00 to $154.00 in a report issued on Tuesday morning,Benzinga reports. The Goldman Sachs Group currently has a buy rating on the healthcare product maker’s stock. Several other analysts have also issued reports on ABT. StockNews.com lowered shares […]
